L-carnitine supplementation and plasma fatty acid status in patients with end-stage renal disease on regular hemodialysis

被引：0
|
作者：
Sulyok, Endre [1 ]
Csiky, Botond [2 ]
Marosvoelgyi, Tamas [3 ]
Decsi, Tamas [3 ]
Bene, Judit [4 ]
Melegh, Bcla [4 ]
机构：
[1] Univ Pecs, Inst Hlth Sci, Pecs, Hungary
[2] FMC Dialysis Ctr Pecs, Pecs, Hungary
[3] Univ Pecs, Dept Pediat, Pecs, Hungary
[4] Univ Pecs, Dept Med Genet, Pecs, Hungary
来源：
PEDIATRIC NEPHROLOGY | 2012年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1682 / 1682
页数：1
相关论文
共 50 条
  • [1] L-Carnitine Supplementation and Adipokines in Patients with End-Stage Renal Disease on Regular Hemodialysis
    Csiky, B.
    Nyul, Z.
    Toth, G.
    Wittmann, I.
    Melegh, B.
    Rauh, M.
    Rascher, W.
    Sulyok, E.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (10) : 735 - 740
  • [2] l-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis
    Di Liberato, Lorenzo
    Arduini, Arduino
    Rossi, Claudia
    Di Castelnuovo, Augusto
    Posari, Cosima
    Sacchetta, Paolo
    Urbani, Andrea
    Bonomini, Mario
    [J]. JOURNAL OF NEPHROLOGY, 2014, 27 (06) : 699 - 706
  • [3] l-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis
    Lorenzo Di Liberato
    Arduino Arduini
    Claudia Rossi
    Augusto Di Castelnuovo
    Cosima Posari
    Paolo Sacchetta
    Andrea Urbani
    Mario Bonomini
    [J]. Journal of Nephrology, 2014, 27 : 699 - 706
  • [4] Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis
    Evans, AM
    Faull, R
    Fornasini, G
    Lemanowicz, EF
    Longo, A
    Pace, S
    Nation, RL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (03) : 238 - 249
  • [5] Effect of hemodialysis session on the dynamics of carnitine ester profile changes in l-carnitine pretreated end-stage renal disease patients
    Csiky, Botond
    Bene, Judit
    Wittmann, Istvan
    Sulyok, Endre
    Melegh, Bela
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (03) : 847 - 855
  • [6] Effect of hemodialysis session on the dynamics of carnitine ester profile changes in l-carnitine pretreated end-stage renal disease patients
    Botond Csiky
    Judit Bene
    Istvan Wittmann
    Endre Sulyok
    Bela Melegh
    [J]. International Urology and Nephrology, 2013, 45 : 847 - 855
  • [7] Carnitine replacement in end-stage renal disease and hemodialysis
    Calvani, M
    Benatti, P
    Mancinelli, A
    D'Iddio, S
    Giordano, V
    Koverech, A
    Amato, A
    Brass, EP
    [J]. CARNITINE: THE SCIENCE BEHIND A CONDITIONALLY ESSENTIAL NUTRIENT, 2004, 1033 : 52 - 66
  • [8] Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
    Bonomini, Mario
    Di Liberato, Lorenzo
    Zammit, Victor
    Arduini, Arduino
    [J]. MOLECULES, 2019, 24 (19):
  • [9] L-Carnitine Supplementation in Hemodialysis Patients
    Mitwalli, Ahmed Hassan
    Al-Wakeel, Jamal S.
    Alam, Awatif
    Tarif, Nauman
    Abu-Aisha, Hassan
    Rashed, Mohamed
    Al Nahed, Nora
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2005, 16 (01) : 17 - 22
  • [10] Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
    Evans, AM
    Faull, RJ
    Nation, RL
    Prasad, S
    Elias, T
    Reuter, SE
    Fornasini, G
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (04) : 1527 - 1534
12345